ALPL Gene Hypophosphatasia Infantile NGS Genetic DNA Test
Introduction
The ALPL Gene Hypophosphatasia Infantile NGS Genetic DNA Test is a specialized genetic test designed to detect mutations in the ALPL gene, which are responsible for Hypophosphatasia, a rare metabolic disorder that affects bone mineralization. Early diagnosis can significantly improve the quality of life for affected infants by allowing for timely interventions.
What the Test Measures
This test utilizes Next Generation Sequencing (NGS) technology to analyze the ALPL gene. It detects specific mutations that lead to Hypophosphatasia, providing crucial information for diagnosis and management.
Who Should Consider This Test
Parents or guardians of infants displaying the following symptoms should consider this test:
- Unexplained fractures or bone pain
- Delayed growth and development
- Dental abnormalities
- Family history of Hypophosphatasia
Benefits of Taking the Test
- Early diagnosis leads to better management of the condition.
- Provides clarity on the genetic basis of the disorder.
- Informs treatment options and family planning.
- Helps in understanding the prognosis of the affected child.
Understanding Your Results
Results from the ALPL Gene Hypophosphatasia Infantile NGS Genetic DNA Test will indicate whether mutations are present in the ALPL gene. A genetic counseling session is recommended to help interpret the results and discuss the implications for the child and family.
Test Name and Price
Test Name | Discount Price | Regular Price |
---|---|---|
ALPL Gene Hypophosphatasia Infantile NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Book Your Test Today
We have branches across all major cities in Kenya, and we also offer home sample collection services. Don’t wait for symptoms to worsen; book the ALPL Gene Hypophosphatasia Infantile NGS Genetic DNA Test today!
For inquiries or to book your test, call or WhatsApp us at +254711564616.
Additional Information
Turnaround time for results is approximately 3 to 4 weeks. Sample types accepted include blood, extracted DNA, or one drop of blood on an FTA card. Please ensure that a clinical history of the patient is available and consider a genetic counseling session to draw a pedigree chart of family members affected with Hypophosphatasia.